Clinical Interchange™: Addressing Cultural Competencies Within Special Populations in MS

Released On
November 20, 2019

Expires On
November 20, 2020

Media Type

Completion Time
90 minutes

Case Management, Geriatric Medicine, Home Care, Neurology, Primary Care


Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.


Supported by an educational grant from Biogen, Celgene Corporation, and Sanofi Genzyme.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • Nurses — maximum of 1.5 contact hours.

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This online educational activity is directed toward neurologists, primary care physicians, nurse practitioners, and physician assistants.

Program Overview

Multiple sclerosis (MS) is the most common immune-mediated demyelinating disease of the central nervous system. Although MS has long been considered a disease that affects predominately individuals of northern European descent, recent data suggest the incidence of MS in the United States is highest in African Americans. In addition, the clinical presentation of MS is variable among African Americans, Hispanic Americans, and Asian Americans, with earlier, more aggressive disease leading to greater disability. And although these populations require treatment that aligns with their unique disease presentations, they are substantially underrepresented in clinical trials. Women of childbearing age and children with MS also represent special populations who require unique treatment considerations.

During this Clinical Interchange™, expert faculty will discuss genetic, cultural, and clinical considerations for management of MS in African American, Hispanic American, and Asian American individuals. The panelists will identify barriers that are limiting enrollment in clinical trials as well as strategies and resources to increase awareness and participation. They will also review clinical evidence for treatment of MS in multiethnic populations, pediatric patients, and women interested in family planning.

Benefits of Participating

  • Increase knowledge of differences in the incidence and clinical presentation of MS in multiethnic populations
  • Gain strategies to increase multiethnic patient awareness and participation in clinical trials
  • Increase confidence in discussing safety considerations for patients wanting to start a family
  • Understand the differences in pediatric versus adult MS and treatment strategies for pediatric patients

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review the clinical presentation of MS in multiethnic populations
  • Discuss strategies for overcoming ethnic/cultural barriers to care in patients with MS
  • Discern the clinical considerations specific to pregnancy, pediatric patients, and different ethnic populations
  • Examine the roles of multidisciplinary care teams in the management of MS


Aliza Ben-Zacharia, DNP, ANP, FAAN, PhD Candidate

Assistant Professor of Neurology
Associate Director of the Center of Nursing Research and Innovation
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine
Mount Sinai Medical Center
New York, NY

Victor M. Rivera, MD, FAAN

Distinguished Emeritus Professor
Department of Neurology
Baylor College of Medicine
Houston, TX

Mitzi Joi Williams, MD

CEO and Founder
Joi Life Wellness Group
Mableton, GA

Marcelo Matiello, MD, MSc

Director, Inpatient Services
Massachusetts General Hospital
Assistant Professor of Neurology
Harvard Medical School
Boston, MA

Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hour(s).

Disclosures of Conflicts of Interest

Aliza Ben-Zacharia, DNP, ANP, FAAN, PhD Candidate

  • Grant Research Support: Biogen, Novartis
  • Consultant: Biogen, Genzyme, Genentech, Celgene, Serono.

Victor M. Rivera, MD, FAAN

  • Consultant: Advance Medical; Speakers Bureau: EMD Serono, Roche Laboratories
  • Other:: Travel, Speaker Fees: Americas Committee for Treatment and Research in Multiple Sclerosis, Brazilian Committee for Treatment and Research in Multiple Sclerosis, Latin American Committee for Treatment and Research in Multiple Sclerosis.

Mitzi Joi Williams, MD

  • Consultant: Genentech, Novartis, Biogen Idec, Celgene, EMD Serono, Sanofi/Genzyme
  • Speakers Bureau: Genentech, Novartis, TEVA, Biogen Idec, EMD Serono, Sanofi/Genzyme.

Marcelo Matiello, MD, MSc

  • No relevant financial relationships with commercial interests to disclose.

The staff of Physicians' Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.

Method of Participation

Instructions for This Activity and Receiving Credit

  1. You will need to log in to participate in the activity.
  2. Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  3. At the end of the activity, educational content/audio files will be available for your reference.
  4. In order to receive a CME/CE certificate, you must complete the activity.
  5. Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.